Over the last 7 days, the Biotech industry has remained flat, although notably Imugene declined by 13%. As for the longer term, the industry has declined 7.5% in the last year. Looking forward, earnings are forecast to grow by 16% annually.
Has the Australian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Wed, 08 May 2024 | AU$145.0b | AU$22.2b | AU$3.3b | 30.8x | 44.5x | 6.5x |
Fri, 05 Apr 2024 | AU$145.0b | AU$22.2b | AU$3.3b | 31.5x | 44.6x | 6.5x |
Sun, 03 Mar 2024 | AU$143.9b | AU$22.5b | AU$3.3b | 29.6x | 43.7x | 6.4x |
Tue, 30 Jan 2024 | AU$149.1b | AU$20.8b | AU$2.8b | 33.9x | 54.1x | 7.2x |
Thu, 28 Dec 2023 | AU$145.2b | AU$20.1b | AU$2.6b | 34.9x | 54.9x | 7.2x |
Sat, 25 Nov 2023 | AU$131.4b | AU$20.9b | AU$2.8b | 32.4x | 47.3x | 6.3x |
Mon, 23 Oct 2023 | AU$118.5b | AU$21.7b | AU$2.9b | 28.7x | 40.7x | 5.5x |
Wed, 20 Sep 2023 | AU$134.9b | AU$21.3b | AU$2.8b | 31.4x | 48.4x | 6.3x |
Fri, 18 Aug 2023 | AU$137.9b | AU$21.2b | AU$2.5b | 38.5x | 54.2x | 6.5x |
Sun, 16 Jul 2023 | AU$135.5b | AU$17.6b | AU$2.3b | 36.9x | 59.9x | 7.7x |
Tue, 13 Jun 2023 | AU$155.9b | AU$17.8b | AU$2.3b | 41x | 67.9x | 8.8x |
Thu, 11 May 2023 | AU$155.5b | AU$17.8b | AU$2.3b | 42.1x | 67.9x | 8.7x |
Sat, 08 Apr 2023 | AU$153.0b | AU$18.0b | AU$2.3b | 41x | 65.8x | 8.5x |
Mon, 06 Mar 2023 | AU$149.5b | AU$17.7b | AU$2.3b | 41.4x | 64.7x | 8.4x |
Wed, 01 Feb 2023 | AU$152.1b | AU$15.4b | AU$2.4b | 52.1x | 62.5x | 9.9x |
Fri, 30 Dec 2022 | AU$145.7b | AU$16.0b | AU$2.6b | 46x | 57x | 9.1x |
Sun, 27 Nov 2022 | AU$153.1b | AU$15.9b | AU$2.5b | 43.5x | 60.3x | 9.6x |
Tue, 25 Oct 2022 | AU$137.0b | AU$17.0b | AU$2.7b | 39.3x | 50.2x | 8.1x |
Thu, 22 Sep 2022 | AU$143.2b | AU$16.1b | AU$2.6b | 42.8x | 55.8x | 8.9x |
Sat, 20 Aug 2022 | AU$149.8b | AU$15.5b | AU$2.7b | 42.1x | 56.4x | 9.7x |
Mon, 18 Jul 2022 | AU$151.4b | AU$15.8b | AU$2.9b | 38.3x | 52.9x | 9.6x |
Wed, 15 Jun 2022 | AU$132.9b | AU$15.6b | AU$2.8b | 33.1x | 47.3x | 8.5x |
Fri, 13 May 2022 | AU$139.3b | AU$15.5b | AU$2.8b | 35.8x | 49x | 9x |
Sun, 10 Apr 2022 | AU$135.2b | AU$14.4b | AU$2.6b | 38.5x | 51.7x | 9.4x |
Tue, 08 Mar 2022 | AU$127.5b | AU$14.7b | AU$2.7b | 38.9x | 47.9x | 8.7x |
Thu, 03 Feb 2022 | AU$136.1b | AU$14.7b | AU$2.8b | 37.6x | 48.5x | 9.2x |
Sat, 01 Jan 2022 | AU$150.9b | AU$14.4b | AU$2.7b | 40.5x | 55x | 10.5x |
Mon, 29 Nov 2021 | AU$154.6b | AU$14.7b | AU$2.8b | 42.6x | 55.1x | 10.5x |
Wed, 27 Oct 2021 | AU$147.5b | AU$14.0b | AU$2.6b | 42.6x | 56.1x | 10.6x |
Fri, 24 Sep 2021 | AU$155.7b | AU$14.4b | AU$2.7b | 43.6x | 57.2x | 10.8x |
Sun, 22 Aug 2021 | AU$150.1b | AU$14.0b | AU$2.6b | 44x | 57.2x | 10.7x |
Fri, 09 Jul 2021 | AU$141.3b | AU$14.0b | AU$2.6b | 41x | 53.8x | 10.1x |
50.3x
Which industries have driven the changes within the Australian Healthcare industry?
AU Market | 1.62% | |
Healthcare | 1.02% | |
Biotech | 1.11% | |
Biotech | 1.11% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
CSL CSL | AU$279.56 | 1.0% +AU$1.4b | -6.8% | PE36.1x | |
MSB Mesoblast | AU$1.18 | 18.7% +AU$211.1m | 13.0% | PS118.6x | |
IMM Immutep | AU$0.48 | 12.8% +AU$65.4m | 102.1% | PS146.7x | |
PYC PYC Therapeutics | AU$0.11 | 13.4% +AU$60.7m | 71.9% | PS24.2x | |
OPT Opthea | AU$0.65 | 4.8% +AU$19.9m | -5.1% | PS728.7x |